Results for parkinsonizma translation from Slovenian to English

poslabšanje parkinsonizma, omotičnost, distonija, hiperkinezija
parkinsonism aggravated, dizziness, dystonia, hyperkinesia

diskinezija poslabšanje parkinsonizma, vrtoglavost, distonija, hiperkinezija
parkinsonism aggravated, dizziness, dystonia, hyperkinesia

pogosti: poslabšanje parkinsonizma, omotičnost, distonija, hiperkinezija
common: parkinsonism aggravated, dizziness, dystonia, hyperkinesia

anjih je bila incidenca parkinsonizma in distonije pri bolnikih, zdravljenih z
6 in clinical trials, the incidence of parkinsonism and dystonia in olanzapine-treated patients was numerically higher, but not statistically significantly different from placebo.

pri bolnikih s parkinsonovo boleznijo lahko antipsihotiki poslabšajo že prisotne simptome parkinsonizma.
if prescribed to patients with parkinson’s disease, antipsychotic medicinal products may exacerbate the underlying parkinsonism symptoms.

z olanzapinom zdravljeni bolniki so imeli manjšo incidenco parkinsonizma, akatizije in distonije v primerjavi s titriranimi odmerki haloperidola.
olanzapine-treated patients had a lower incidence of parkinsonism, akathisia and dystonia compared with titrated doses of haloperidol.

6 v kliničnih preskušanjih je bila incidenca parkinsonizma in distonije pri bolnikih, zdravljenih z olanzapinom, številčno večja, a se ni statistično značilno razlikovala od placeba.
6 in clinical trials, the incidence of parkinsonism and dystonia in olanzapine-treated patients was numerically higher, but not statistically significantly different from placebo.

pri bolnikih, zdravljenih z olanzapinom, je bila incidenca parkinsonizma, akatizije in distonije manjša v primerjavi z bolniki, ki so jim odmerke haloperidola povečevali postopno.
olanzapine-treated patients had a lower incidence of parkinsonism, akathisia and dystonia compared with titrated doses of haloperidol.

6v kliničnih preizkušanjih je bila incidenca parkinsonizma in distonije pri bolnikih, zdravljenih z olanzapinom, pogostejša, a se ni statistično značilno razlikovala od skupine, ki je jemala placebo.
6 in clinical trials, the incidence of parkinsonism and dystonia in olanzapine-treated patients was numerically higher, but not statistically significantly different from placebo.

zelo redko bolniki razvijejo maligni nevroleptični sindrom (resni simptomi mišične togosti, zvišana telesna temperatura ali zmedenost), ko se zdravila za zdravljenje parkinsonizma nenadno zmanjšajo ali ukinejo.
very rarely, patients develop neuroleptic malignant syndrome (severe symptoms of muscle stiffening, fever or mental confusion) when antiparkinsonian treatments are abruptly reduced or withdrawn.

na podlagi kratkotrajnih (6-tedenskih) preskušanj pri bolnikih s shizofrenijo je videti, da obstaja pri bolnikih, zdravljenih z asenapinom, v primeru akatizije povezanost med odmerkom zdravila in odzivom nanj, v primeru parkinsonizma pa so opazili tendenco okrepitve pri večjih odmerkih.
from the short-term (6 weeks) schizophrenia trials there appears to be a dose-response relationship for akathisia in patients treated with asenapine, and for parkinsonism there was an increasing trend with higher doses.